Annexon Inc Annual Shareholders Meeting Transcript
Welcome to the Annexon 2023 Annual Meeting of Stockholders. Our host for today's call is Douglas Love, President & Chief Executive Officer. (Operator Instructions)
I will now turn the call over to your host, Douglas Love. You may begin.
Thank you. good morning. Hi, I'm Douglas Love, President and CEO of Annexon Biosciences. I'm very happy to welcome you to Annexon's 2023 Annual Meeting of Stockholders.
Over the first half of 2023, we continued to make meaningful progress across our portfolio of novel complement-mediated therapeutics for several indications of unmet need, thereby setting up a strong foundation for growth in the second half of 2023 and beyond.
Most recently in May, we announced positive top-line data from our Phase 2 ARCHER trial of ANX007 in patients with geographic atrophy. There, we demonstrated for the first time statistically significant preservation of visual function. These results add to our growing body of clinical evidence that by targeting classical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |